Novartis Bests Defect Claims In Trileptal Suit
With a court's dismissal of certain liability claims, Novartis Pharmaceuticals Corp. has gained the upper hand over allegations that its epilepsy treatment Trileptal caused an Ohio woman to develop serious health...To view the full article, register now.
Already a subscriber? Click here to view full article